QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study
CONCLUSION: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.PMID:38073101 | DOI:10.2174/0115701611250248231114114557 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Andrea Sartorio Giulia Burrei Luca Cristin Mirko Zoncap è Michele Carlin Enrico Tadiello Pietro Minuz Andrea Dalbeni Simone Romano Source Type: research
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices
Curr Vasc Pharmacol. 2023 Dec 8. doi: 10.2174/0115701611233184231206100222. Online ahead of print.ABSTRACTLarge bore accesses refer to accesses with a diameter of 10 French or greater and are necessary for various medical devices, including those used in transcatheter aortic valve replacement, endovascular aneurysm repair stent-grafts, and percutaneous mechanical support devices. Notably, the utilization of these devices via femoral access is steadily increasing due to advancements in technology and implantation techniques, which are expanding the pool of patients suitable for percutaneous procedures. However, procedures i...
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Sabato Sorrentino Assunta Di Costanzo Nadia Salerno Alessandro Caracciolo Federica Bruno Alessandra Panarello Antonio Bellantoni Annalisa Mongiardo Ciro Indolfi Source Type: research
QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study
CONCLUSION: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.PMID:38073101 | DOI:10.2174/0115701611250248231114114557 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Andrea Sartorio Giulia Burrei Luca Cristin Mirko Zoncap è Michele Carlin Enrico Tadiello Pietro Minuz Andrea Dalbeni Simone Romano Source Type: research
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices
Curr Vasc Pharmacol. 2023 Dec 8. doi: 10.2174/0115701611233184231206100222. Online ahead of print.ABSTRACTLarge bore accesses refer to accesses with a diameter of 10 French or greater and are necessary for various medical devices, including those used in transcatheter aortic valve replacement, endovascular aneurysm repair stent-grafts, and percutaneous mechanical support devices. Notably, the utilization of these devices via femoral access is steadily increasing due to advancements in technology and implantation techniques, which are expanding the pool of patients suitable for percutaneous procedures. However, procedures i...
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Sabato Sorrentino Assunta Di Costanzo Nadia Salerno Alessandro Caracciolo Federica Bruno Alessandra Panarello Antonio Bellantoni Annalisa Mongiardo Ciro Indolfi Source Type: research
QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study
CONCLUSION: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.PMID:38073101 | DOI:10.2174/0115701611250248231114114557 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Andrea Sartorio Giulia Burrei Luca Cristin Mirko Zoncap è Michele Carlin Enrico Tadiello Pietro Minuz Andrea Dalbeni Simone Romano Source Type: research
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices
Curr Vasc Pharmacol. 2023 Dec 8. doi: 10.2174/0115701611233184231206100222. Online ahead of print.ABSTRACTLarge bore accesses refer to accesses with a diameter of 10 French or greater and are necessary for various medical devices, including those used in transcatheter aortic valve replacement, endovascular aneurysm repair stent-grafts, and percutaneous mechanical support devices. Notably, the utilization of these devices via femoral access is steadily increasing due to advancements in technology and implantation techniques, which are expanding the pool of patients suitable for percutaneous procedures. However, procedures i...
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Sabato Sorrentino Assunta Di Costanzo Nadia Salerno Alessandro Caracciolo Federica Bruno Alessandra Panarello Antonio Bellantoni Annalisa Mongiardo Ciro Indolfi Source Type: research
QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study
CONCLUSION: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.PMID:38073101 | DOI:10.2174/0115701611250248231114114557 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Andrea Sartorio Giulia Burrei Luca Cristin Mirko Zoncap è Michele Carlin Enrico Tadiello Pietro Minuz Andrea Dalbeni Simone Romano Source Type: research
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices
Curr Vasc Pharmacol. 2023 Dec 8. doi: 10.2174/0115701611233184231206100222. Online ahead of print.ABSTRACTLarge bore accesses refer to accesses with a diameter of 10 French or greater and are necessary for various medical devices, including those used in transcatheter aortic valve replacement, endovascular aneurysm repair stent-grafts, and percutaneous mechanical support devices. Notably, the utilization of these devices via femoral access is steadily increasing due to advancements in technology and implantation techniques, which are expanding the pool of patients suitable for percutaneous procedures. However, procedures i...
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Sabato Sorrentino Assunta Di Costanzo Nadia Salerno Alessandro Caracciolo Federica Bruno Alessandra Panarello Antonio Bellantoni Annalisa Mongiardo Ciro Indolfi Source Type: research
QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study
CONCLUSION: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.PMID:38073101 | DOI:10.2174/0115701611250248231114114557 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 11, 2023 Category: Drugs & Pharmacology Authors: Andrea Sartorio Giulia Burrei Luca Cristin Mirko Zoncap è Michele Carlin Enrico Tadiello Pietro Minuz Andrea Dalbeni Simone Romano Source Type: research
Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease
Curr Vasc Pharmacol. 2023 Nov 30. doi: 10.2174/0115701611292747231129080204. Online ahead of print.NO ABSTRACTPMID:38037835 | DOI:10.2174/0115701611292747231129080204 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Kosmas I Paraskevas Debabrata Mukherjee Theofanis T Papas Source Type: research
Study of Osteopontin as a Marker of Arteriovenous Shunt Stenosis in Hemodialysis Patients
CONCLUSION: OPN levels in HD patients may be useful markers for predicting and detecting AVF stenosis.PMID:38038003 | DOI:10.2174/0115701611260120231106081701 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Marwa R Elbarbary Laila A Ahmed Doaa A El-Adl Alshimaa A Ezzat Sherif A Nassib Source Type: research
Evaluation of Clinical, Echocardiographic, and Therapeutic Characteristics, and Prognostic Outcomes of Coexisting Heart Failure among Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
CONCLUSION: Coexisting AF+HF was associated with a more labile and higher-risk population among Jordanian patients. Furthermore, coexisting HF independently predicted higher all-cause mortality and cardiovascular mortality. Efforts should be made to efficiently identify such cases early and treat them aggressively.PMID:38038004 | DOI:10.2174/0115701611260211231115094716 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Nasr Alrabadi Mohammed Al-Nusair Farah K El-Zubi Mais Tashtoush Osama Alzoubi Sa'ed Khamis Majd M Masadeh Karem H Alzoubi Mohammed Al-Hiari Ayman Hammoudeh Source Type: research
Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension
CONCLUSION: Serum Gal-3BP levels were increased in patients with PAH, and levels of Gal-3BP were associated with the severity of PAH. Gal-3BP might have predictive value for the diagnosis and prognosis of PAH.PMID:38038005 | DOI:10.2174/0115701611268078231010072521 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Mingfei Li Wenzhi Pan Dan Tian Dandan Chen Xiaochun Zhang Yuan Zhang Shasha Chen Daxin Zhou Junbo Ge Source Type: research
Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess
In conclusion, CS promotes atherosclerosis, including peripheral artery disease, by causing functional and morphological deterioration of the arterial vessel wall and increasing the presence of classical risk factors of atherosclerosis.PMID:38038006 | DOI:10.2174/0115701611272145231106053914 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: P Poredos G H Schernthaner A Blinc D P Mikhailidis M Jensterle P Anagnostis P L Antignani K Bajuk Studen M Šabović M K Je žovnik Source Type: research
Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease
Curr Vasc Pharmacol. 2023 Nov 30. doi: 10.2174/0115701611292747231129080204. Online ahead of print.NO ABSTRACTPMID:38037835 | DOI:10.2174/0115701611292747231129080204 (Source: Current Vascular Pharmacology)
Source: Current Vascular Pharmacology - December 1, 2023 Category: Drugs & Pharmacology Authors: Kosmas I Paraskevas Debabrata Mukherjee Theofanis T Papas Source Type: research
